|
STAT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.819400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.194400E-01 |
| Normal-vs-Stage2 |
6.209700E-02 |
| Normal-vs-Stage3 |
1.424100E-02 |
| Normal-vs-Stage4 |
3.102600E-03 |
| Stage1-vs-Stage2 |
1.970950E-01 |
| Stage1-vs-Stage3 |
9.347900E-02 |
| Stage1-vs-Stage4 |
1.422310E-02 |
| Stage2-vs-Stage3 |
7.732600E-01 |
| Stage2-vs-Stage4 |
3.347800E-01 |
| Stage3-vs-Stage4 |
1.546820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.878720E-03 |
| Normal-vs-AfricanAmerican |
9.214200E-01 |
| Normal-vs-Asian |
1.960170E-01 |
| Caucasian-vs-AfricanAmerican |
6.325900E-02 |
| Caucasian-vs-Asian |
5.480200E-01 |
| AfricanAmerican-vs-Asian |
1.815840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.058000E-03 |
| Normal-vs-Female |
3.053600E-02 |
| Male-vs-Female |
6.066200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.880200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.645840E-02 |
| Normal-vs-Age(61-80Yrs) |
7.043900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.334800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.223600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.748000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.515000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.148200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.318000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.883600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.294200E-01 |
| Normal-vs-Grade 2 |
1.055040E-01 |
| Normal-vs-Grade 3 |
1.021510E-02 |
| Normal-vs-Grade 4 |
2.998400E-03 |
| Grade 1-vs-Grade 2 |
5.033000E-01 |
| Grade 1-vs-Grade 3 |
1.245030E-01 |
| Grade 1-vs-Grade 4 |
1.220360E-02 |
| Grade 2-vs-Grade 3 |
2.407000E-01 |
| Grade 2-vs-Grade 4 |
2.098000E-02 |
| Grade 3-vs-Grade 4 |
7.895900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.555600E-02 |
| Normal-vs-ccB subtype |
1.324460E-02 |
| ccA subtype-vs-ccB subtype |
4.809200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.382700E-03 |
| Normal-vs-N1 |
1.141020E-01 |
| N0-vs-N1 |
2.267800E-01 |
|
|
